CTLA4 and melanoma: Also, in several in vivomodels for disease disorders, it was demonstrated that CTLA-4 blockadeabrogates the suppressive function of murine (e.g., inflammatory bowel disease[40]) and human (e.g., melanoma patients [41–44]) Tregs.